Division of Nephrology and Hypertension

Arroyo, Terker receive new awards from ASCI

Juan Pablo Arroyo, MD, PhD, instructor of Medicine in the Division of Nephrology and Hypertension, and Andrew Terker, MD, PhD, research fellow in Nephrology, each received an inaugural 2022 Emerging Generation Award from the American Society for Clinical Investigation.

Schaefer named Adult Solid Organ Transplant Center medical director

Heidi Schaefer, MD, has been named medical director of the Adult Solid Organ Transplant Center at Vanderbilt University Medical Center.

Study compares kidney injury risk for COVID, flu patients

A Vanderbilt study found that renin-angiotensin-aldosterone system (RAASi) inhibitor drugs, which are commonly used to regulate high blood pressure, do not disproportionately increase the risk of acute kidney injury (AKI) in patients with COVID-19 compared to patients hospitalized with influenza.

Corina Borza, PhD, left, Ambra Pozzi, PhD, and colleagues are studying a certain cell surface receptor’s role in the process that leads to kidney failure.

VUMC study raises hope for improving treatment of kidney disease

Vanderbilt research has revealed an important mechanism in the kidney by which a cell surface receptor known as DDR1 fans the flames of inflammation and fibrosis that ultimately lead to kidney failure.

Accelerating podocyte production

A new method developed by Vanderbilt researchers to generate kidney cells from stem cells offers a faster and less expensive way to make these valuable tools for studying kidney diseases.

Pozzi elected president of Society for Matrix Biology

Vanderbilt’s Ambra Pozzi, PhD, has been elected president of the American Society for Matrix Biology (ASMB), a scientific organization that promotes research on the extracellular matrix with the aim of improving human health.

1 2 3 4 5 9